Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
Go back to Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment| (NASDAQ: EDSA) | Delayed: 2.69 +0.04 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $ | |||
| Open | $2.62 | 52 Week Low | $ | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.56 | EPS | $ | |||
| Volume | 46,735 | |||||



